IP Library Patent Application 17962626
Patent Application
App. No. 17/962,626

COMPOSITIONS COMPRISING EPHEDRINE OR AN EPHEDRINE SALT AND METHODS OF MAKING AND USING SAME

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/962,626
Abstract

The present disclosure provides compositions comprising ephedrine sulfate ready for immediate use in a clinical setting, and methods of making and using same.

Claims (7)

1 . A storage-stable, sterile, ready-to-use ephedrine solution comprising:

5 mg/mL ephedrine sulfate;

9 mg/mL sodium chloride;

no preservative;

water;

an initial pH level of about 4.5 to about 7; and

a pH level within 0.5 pH units of the initial pH level after storage at 25° C. and 60% relative humidity for 12 months or after storage at 40° C. and 75% relative humidity for 6 months.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jun 3, 2024
From: SAGENT GROUP, LLC
To: NEXUS PHARMACEUTICALS, LLC; NEXPHARM PARENT HOLDCO, LLC; ISOPRO HOLDINGS, LLC
Reel/Frame 067600/0837 →
CHANGE OF NAME Recorded May 26, 2023
From: NEXUS PHARMACEUTICALS II, LLC
To: NEXUS PHARMACEUTICALS, LLC
Reel/Frame 063789/0675 →
STATUTORY CONVERSION Recorded May 24, 2023
From: NEXUS PHARMACEUTICALS, INC.
To: NEXUS PHARMACEUTICALS II, LLC
Reel/Frame 063752/0975 →
SECURITY INTEREST Recorded May 8, 2023
From: NEXUS PHARMACEUTICALS, LLC; NEXPHARM PARENT HOLDCO, LLC; ISOPRO HOLDINGS, LLC
To: SAGENT GROUP, LLC
Reel/Frame 063568/0369 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2022
From: AHMED, SHAHID
To: NEXUS PHARMACEUTICALS, INC.
Reel/Frame 061359/0539 →